Blue Water Life Science Advisors, LP Guardant Health, Inc. Transaction History
Blue Water Life Science Advisors, LP
- $110 Million
- Q4 2024
A detailed history of Blue Water Life Science Advisors, LP transactions in Guardant Health, Inc. stock. As of the latest transaction made, Blue Water Life Science Advisors, LP holds 694,047 shares of GH stock, worth $29.8 Million. This represents 19.29% of its overall portfolio holdings.
Number of Shares
694,047
Previous 451,047
53.87%
Holding current value
$29.8 Million
Previous $10.3 Million
105.02%
% of portfolio
19.29%
Previous 9.09%
Shares
14 transactions
Others Institutions Holding GH
# of Institutions
347Shares Held
120MCall Options Held
793KPut Options Held
1.85M-
Vanguard Group Inc Valley Forge, PA12.1MShares$517 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$482 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT6.42MShares$275 Million8.64% of portfolio
-
Baillie Gifford & CO5.45MShares$234 Million0.13% of portfolio
-
Cadian Capital Management, LP New York, NY5.22MShares$224 Million9.25% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $4.38B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...